The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lacosamide Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Lacosamide Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lacosamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lacosamide Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories and Alembic Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lacosamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Market segment by Application
Adults
Children
Major players covered
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales, revenue and global market share of Lacosamide Tablets from 2018 to 2023.
Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lacosamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.
The global Lacosamide Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lacosamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lacosamide Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories and Alembic Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lacosamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Market segment by Application
Adults
Children
Major players covered
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales, revenue and global market share of Lacosamide Tablets from 2018 to 2023.
Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lacosamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Lacosamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg/tablet
1.3.3 100 mg/tablet
1.3.4 150 mg/tablet
1.3.5 200 mg/tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Lacosamide Tablets Market Size & Forecast
1.5.1 Global Lacosamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lacosamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Lacosamide Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Tablets Product and Services
2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 UCB Recent Developments/Updates
2.2 Aesica Pharmaceuticals GmbH
2.2.1 Aesica Pharmaceuticals GmbH Details
2.2.2 Aesica Pharmaceuticals GmbH Major Business
2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Lacosamide Tablets Product and Services
2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alembic Pharma Recent Developments/Updates
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Tablets Product and Services
2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Recent Developments/Updates
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Accord Healthcare Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Lacosamide Tablets Product and Services
2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 Sun PharmaApotex
2.9.1 Sun PharmaApotex Details
2.9.2 Sun PharmaApotex Major Business
2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun PharmaApotex Recent Developments/Updates
2.10 Jiangxi Qingfeng Pharmaceutical
2.10.1 Jiangxi Qingfeng Pharmaceutical Details
2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
2.11 Beijing Sihuan Pharmaceutical
2.11.1 Beijing Sihuan Pharmaceutical Details
2.11.2 Beijing Sihuan Pharmaceutical Major Business
2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
2.12 Buchang Pharmaceutical
2.12.1 Buchang Pharmaceutical Details
2.12.2 Buchang Pharmaceutical Major Business
2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Buchang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Lacosamide Tablets by Manufacturer
3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lacosamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Lacosamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Lacosamide Tablets Manufacturer Market Share in 2022
3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Lacosamide Tablets Market: Region Footprint
3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Lacosamide Tablets Market Size by Region
4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Lacosamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Lacosamide Tablets Average Price by Region (2018-2029)
4.2 North America Lacosamide Tablets Consumption Value (2018-2029)
4.3 Europe Lacosamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029)
4.5 South America Lacosamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Lacosamide Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Lacosamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Lacosamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Lacosamide Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Lacosamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Lacosamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Lacosamide Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Lacosamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Lacosamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Lacosamide Tablets Market Size by Country
7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Lacosamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Lacosamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Lacosamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Lacosamide Tablets Market Size by Country
8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Lacosamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Lacosamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Lacosamide Tablets Market Size by Country
10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Lacosamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Lacosamide Tablets Market Drivers
12.2 Lacosamide Tablets Market Restraints
12.3 Lacosamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lacosamide Tablets
13.3 Lacosamide Tablets Production Process
13.4 Lacosamide Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lacosamide Tablets Typical Distributors
14.3 Lacosamide Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
